These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31650274)

  • 1. On-Demand Manufacturing of Direct Compressible Tablets: Can Formulation Be Simplified?
    Azad MA; Osorio JG; Wang A; Klee DM; Eccles ME; Grela E; Sloan R; Hammersmith G; Rapp K; Brancazio D; Myerson AS
    Pharm Res; 2019 Oct; 36(12):167. PubMed ID: 31650274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system II: pellets containing different active pharmaceutical ingredients.
    Hamman H; Hamman J; Wessels A; Scholtz J; Steenekamp J
    Pharm Dev Technol; 2019 Feb; 24(2):145-156. PubMed ID: 29394129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Critical Material Attributes (CMAs)-Particle Shape on Miniature Pharmaceutical Unit Operations.
    Azad MA; Capellades G; Wang AB; Klee DM; Hammersmith G; Rapp K; Brancazio D; Myerson AS
    AAPS PharmSciTech; 2021 Mar; 22(3):98. PubMed ID: 33709195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression.
    Chattoraj S; Sun CC
    J Pharm Sci; 2018 Apr; 107(4):968-974. PubMed ID: 29247737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.
    Sun WJ; Aburub A; Sun CC
    J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
    Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
    J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A compact, portable, re-configurable, and automated system for on-demand pharmaceutical tablet manufacturing.
    Azad MA; Osorio JG; Brancazio D; Hammersmith G; Klee DM; Rapp K; Myerson A
    Int J Pharm; 2018 Mar; 539(1-2):157-164. PubMed ID: 29366938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous manufacturing of extended release tablets via powder mixing and direct compression.
    Ervasti T; Simonaho SP; Ketolainen J; Forsberg P; Fransson M; Wikström H; Folestad S; Lakio S; Tajarobi P; Abrahmsén-Alami S
    Int J Pharm; 2015 Nov; 495(1):290-301. PubMed ID: 26320548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the API properties on the ODTs manufacturing from co-processed excipient systems.
    Krupa A; Jachowicz R; Pędzich Z; Wodnicka K
    AAPS PharmSciTech; 2012 Dec; 13(4):1120-9. PubMed ID: 22941425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets.
    Kokott M; Lura A; Breitkreutz J; Wiedey R
    Eur J Pharm Biopharm; 2021 Nov; 168():122-130. PubMed ID: 34474110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particle Engineering of Excipients for Direct Compression: Understanding the Role of Material Properties.
    Mangal S; Meiser F; Morton D; Larson I
    Curr Pharm Des; 2015; 21(40):5877-89. PubMed ID: 26446468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dry coating of micronized API powders for improved dissolution of directly compacted tablets with high drug loading.
    Han X; Ghoroi C; Davé R
    Int J Pharm; 2013 Feb; 442(1-2):74-85. PubMed ID: 22921376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Coprocessed Chitin-Calcium Carbonate as Multifunctional Tablet Excipient for Direct Compression, Part 2: Tableting Properties.
    Chaheen M; Bataille B; Yassine A; Belamie E; Sharkawi T
    J Pharm Sci; 2019 Oct; 108(10):3319-3328. PubMed ID: 31145923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding the small size challenges of mini-tablets for enhanced dose flexibility and micro-dosing.
    Mitra B; Thool P; Meruva S; Aycinena JA; Li J; Patel J; Patel K; Agarwal A; Karki S; Bowen W
    Int J Pharm; 2020 Jan; 574():118905. PubMed ID: 31809860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplified end-to-end continuous manufacturing by feeding API suspensions in twin-screw wet granulation.
    Schmidt A; de Waard H; Moll KP; Kleinebudde P; Krumme M
    Eur J Pharm Biopharm; 2018 Dec; 133():224-231. PubMed ID: 30291963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of direct compression powder blend transfer method from the container to the tablet press on product critical quality attributes: a case study.
    Teżyk M; Jakubowska E; Milczewska K; Milanowski B; Voelkel A; Lulek J
    Drug Dev Ind Pharm; 2017 Jun; 43(6):911-916. PubMed ID: 28032521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
    Kunnath K; Huang Z; Chen L; Zheng K; Davé R
    Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Aquasolv Lignin in ibuprofen-loaded pharmaceutical formulations obtained via direct compression and wet granulation.
    Gil-Chávez J; Padhi SSP; Leopold CS; Smirnova I
    Int J Biol Macromol; 2021 Mar; 174():229-239. PubMed ID: 33454332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplified formulations with high drug loads for continuous twin-screw granulation.
    Meier R; Thommes M; Rasenack N; Krumme M; Moll KP; Kleinebudde P
    Int J Pharm; 2015 Dec; 496(1):12-23. PubMed ID: 26024821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microcrystalline cellulose based drug-composite formulation strategy for developing low dose drug tablets.
    Sun WJ; Sun CC
    Int J Pharm; 2020 Jul; 585():119517. PubMed ID: 32526333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.